Jiangmen Central Hospital
🇨🇳China
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma
Phase 2
- Conditions
- Advanced Cholangiocarcinoma
- Interventions
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Jiangmen Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03982680
- Locations
- 🇨🇳
Jiangmen central hospital, Jiangmen, Guangdong, China
The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Jiangmen Central Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT01732276
News
No news found